Although no shared rare variant was identified in the candidate corneal dystrophy gene DCN, given the greatly reduced levels of decorin immunoreactivity in the affected cornea we further examined this genomic region to assess if a variant was missed in our WGS analysis pipeline. The gene discussed is DCN; the disease is corneal dystrophy.